Ticker Symbol: TBPH
Theravance Biopharma Inc
$7.99 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Cayman Islands
Currency:
USD
Asset
Type: Common Stock
CIK:0001583107
Company Profile
Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its research is focused in the areas of inflammation and immunology.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Ugland House, South Church Street
Website: www.theravance.com
CEO: Rick Winningham
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $8.58
Change:
-$0.10
(
-1.15%)
Days Range: $8.52 - $8.67
Beta: 0.60
52wk. High: $12.03
52wk. Low: $8.25
Ytd. Change -23.79%
50 Day Moving Average: $9.18
200 Day Moving Average: $10.19
Shares Outstanding: 52813104
Valuation
Market Cap: 45.3B
PE Ratio: -
EPS (TTM): 13.24
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A